Air Liquide has entered into exclusive negotiations with global investment organisation EQT for the potential sale of its subsidiary Schülke & Mayr GmbH.
Headquartered in Germany, Schülke & Mayr has been a leader in infection prevention and hygiene for more than 130 years.
The company develops, produces and distributes antiseptics for wound care, disinfectants, medical and cosmetic skin care products and preservatives.
Air Liquide first announced the potential sale in November 2019, illustrating its strategy to review its business portfolio regularly and to focus on its core gases and healthcare businesses, thereby enhancing Air Liquide’s performance.
... to continue reading you must be subscribed
